EUVIMEDEUVIMED entdecken
Video/Audio

Cell-free DNA assay for malignancy classification of high-risk lung nodules

Siwei Wang, Fanchen Meng, Peng Chen, Yang Lv, Min Wu, Haimeng Tang, Hua Bao, Xue Wu, Yang Shao, Jie Wang, Juncheng Dai, Lin Xu und 2 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2024-11 · 168 (5) · e140-e175

DOI: 10.1016/j.jtcvs.2024.04.026 ↗

Kurz gefasst

Video/Audio in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024-11. Verfasst von Siwei Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer H…. Hauptthemen laut MEDLINE: Lung Neoplasms, Cell-Free Nucleic Acids, Multiple Pulmonary Nodules. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science Fund for Distinguished Young Scholars of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Although low-dose computed tomography has been proven effective to reduce lung cancer-specific mortality, a considerable proportion of surgically resected high-risk lung nodules were still confirmed pathologically benign. There is an unmet need of a novel method for malignancy classification in lung nodules. METHODS: We recruited 307 patients with high-risk lung nodules who underwent curative surgery, and 247 and 60 cases were pathologically confirmed malignant and benign lung lesions, respectively. Plasma samples from each patient were collected before surgery and performed low-depth (5×) whole-genome sequencing. We extracted cell-free DNA characteristics and determined radiomic features. We built models to classify the malignancy using our data and further validated models with 2 independent lung nodule cohorts. RESULTS: Our models using one type of profile were able to distinguish lung cancer and benign lung nodules at an area under the curve metrics of 0.69 to 0.91 in the study cohort. Integrating all the 5 base models using cell-free DNA profiles, the cell-free DNA-based ensemble model achieved an area under the curve of 0.95 (95% CI, 0.92-0.97) in the study cohort and 0.98 (95% CI, 0.96-1.00) in the validation cohort. At a specificity of 95.0%, the sensitivity reached 80.0% in the study cohort. With the same threshold, the specificity and sensitivity had similar performances in both validation cohorts. Furthermore, the performance of area under the curve reached 0.97 in both the study and validation cohorts when considering the radiomic profile. CONCLUSIONS: The cell-free DNA profiles-based method is an efficient noninvasive tool to distinguish malignancies and high-risk but pathologically benign lung nodules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCell-Free Nucleic AcidsMultiple Pulmonary NodulesHumansMaleFemaleMiddle AgedAgedPredictive Value of TestsBiomarkers, TumorReproducibility of ResultsRisk AssessmentSolitary Pulmonary Nodule

Stichwörter der Autor:innen

cell-free DNA fragmentomicsliquid biopsylung cancerradiomicswhole-genome sequencing

Substanzen

Cell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Resear…
  • Department of Information Center, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China.
  • Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China; School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Science and Technology, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China; Biobank of Lung Cancer, Jiangsu Biob…
  • School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.

Förderung

  • National Key Research and Development Program of China
  • Science Fund for Distinguished Young Scholars of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, S., Meng, F., Chen, P., Lv, Y., Wu, M., Tang, H., Bao, H., Wu, X., Shao, Y., Wang, J., Dai, J., Xu, L., Wang, X., & Yin, R. (2024). Cell-free DNA assay for malignancy classification of high-risk lung nodules. The Journal of Thoracic and Cardiovascular Surgery, 168(5), e140-e175. https://doi.org/10.1016/j.jtcvs.2024.04.026

Vancouver

Wang S, Meng F, Chen P, Lv Y, Wu M, Tang H, et al. Cell-free DNA assay for malignancy classification of high-risk lung nodules. The Journal of Thoracic and Cardiovascular Surgery. 2024;168(5):e140-e175. doi:10.1016/j.jtcvs.2024.04.026

BibTeX
@article{Wang2024,
  author = {Wang, Siwei and Meng, Fanchen and Chen, Peng and Lv, Yang and Wu, Min and Tang, Haimeng and Bao, Hua and Wu, Xue and Shao, Yang and Wang, Jie and Dai, Juncheng and Xu, Lin and Wang, Xiaoxiao and Yin, Rong},
  title = {Cell-free DNA assay for malignancy classification of high-risk lung nodules},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  volume = {168},
  number = {5},
  pages = {e140--e175},
  doi = {10.1016/j.jtcvs.2024.04.026}
}
Kostenlos starten →